Company intelligence / Profile preview

TCI Gene

Taipei City, Taipei City, Taiwantci-gene.com ↗

Ownership: Private
Development stage: Other

Overview

TCI Gene is a leading Taiwanese biotech specializing in gene testing services, stem cell-based medicinal products including natural killer cells, virus detection services, personalized gene health foods/supplements, and human stem cell therapy. It operates globally with a focus on precision medicine solutions spanning preventive diagnostics to advanced therapies. The company is part of the larger TCI group which has extensive CDMO capabilities across supplements/health foods/skincare as well as medical devices through its subsidiaries[1][2][3].

Therapeutic areas: Infectious DiseasesOther
Modalities: Gene therapyCell therapyStem cell therapyPersonalized health food (nutraceuticals/functional foods)
Industry: Biotech

Drug pipeline

1 asset

streptococcus thermophilus TCI633

Unknown

Beyond the preview

Go deeper on TCI Gene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TCI Gene.

Explore the full profile